0.37 -0.01 (-2.63%)

85.71% Fall from 52W High

1.5M XNAS Volume

XNAS 18 Mar, 2025 1:48 PM (EDT)

Board Meeting
The next board meeting for Lexicon Pharmaceuticals Inc is on 25 Mar 2025 for the purpose of Lexicon Pharmaceuticals Inc Annual Report for 2024 See details


Insider Trading disclosures for Lexicon Pharmaceuticals Inc

The latest disclosure was made by Alan J. Main in Lexicon Pharmaceuticals Inc where a trade of 68,243 Restricted Stock Units done was reported to US exchanges on Feb. 28, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 68,243 136,487 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 25,667 281,391 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 32,904 314,295 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 68,243 382,538 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. 28 Feb 2025 43,434 339,104 (0%) 0% 0.7 29,101 Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 25,667 0 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 32,904 32,903 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 69,387 306,437 (0%) 0% - Common Stock
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 69,387 138,773 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 33,456 33,457 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 26,097 0 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 26,097 203,594 (0%) 0% - Common Stock
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 33,456 237,050 (0%) 0% - Common Stock
Brian T. Crum SVP, General Counsel & Secr. Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. 28 Feb 2025 45,622 260,815 (0%) 0% 0.7 30,567 Common Stock
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 19,887 39,773 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 10,617 58,417 (0%) 0% - Common Stock
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 15,926 74,343 (0%) 0% - Common Stock
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 19,887 94,230 (0%) 0% - Common Stock
Kristen L. Alexander VP, Finance and Accounting Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. 28 Feb 2025 17,862 76,368 (0%) 0% 0.7 11,968 Common Stock
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 10,617 0 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 15,926 15,927 - - Restricted Stock Units
Craig B. Granowitz SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 74,227 148,453 - - Restricted Stock Units
Craig B. Granowitz SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 27,917 75,543 (0%) 0% - Common Stock
Craig B. Granowitz SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 35,790 111,333 (0%) 0% - Common Stock
Craig B. Granowitz SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 74,227 185,560 (0%) 0% - Common Stock
Craig B. Granowitz SVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. 28 Feb 2025 65,308 120,252 (0%) 0% 0.7 43,756 Common Stock
Craig B. Granowitz SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 27,917 0 - - Restricted Stock Units
Craig B. Granowitz SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 35,790 35,790 - - Restricted Stock Units
Wendy E. McDermott SVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. 28 Feb 2025 30,004 121,646 (0%) 0% 0.7 20,103 Common Stock
Wendy E. McDermott SVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 18,943 0 - - Restricted Stock Units
Wendy E. McDermott SVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 27,696 27,697 - - Restricted Stock Units
Wendy E. McDermott SVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 52,317 104,633 - - Restricted Stock Units
Wendy E. McDermott SVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 18,943 71,637 (0%) 0% - Common Stock
Wendy E. McDermott SVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 27,696 99,333 (0%) 0% - Common Stock
Wendy E. McDermott SVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 52,317 151,650 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 502,060 502,060 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 753,090 753,090 - - Stock Option (Right to Buy)
Brian T. Crum SVP, General Counsel & Secr. Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 765,730 765,730 - - Stock Option (Right to Buy)
Brian T. Crum SVP, General Counsel & Secr. Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 510,490 510,490 - - Restricted Stock Units
Scott M. Coiante SVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 480,710 480,710 - - Restricted Stock Units
Scott M. Coiante SVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 721,070 721,070 - - Stock Option (Right to Buy)
Kristen L. Alexander VP, Finance and Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 185,540 185,540 - - Stock Option (Right to Buy)
Kristen L. Alexander VP, Finance and Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 185,540 185,540 - - Restricted Stock Units
Craig B. Granowitz SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 606,780 606,780 - - Restricted Stock Units
Craig B. Granowitz SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 910,170 910,170 - - Stock Option (Right to Buy)
Wendy E. McDermott SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 649,780 649,780 - - Stock Option (Right to Buy)
Wendy E. McDermott SVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 433,180 433,180 - - Restricted Stock Units
Michael Exton Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 1,509,790 1,509,790 - - Restricted Stock Units
Michael Exton Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 2,264,690 2,264,690 - - Stock Option (Right to Buy)
Brian Corrigan SVP, Regulatory & QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 448,660 448,660 - - Restricted Stock Units
Brian Corrigan SVP, Regulatory & QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 673,000 673,000 - - Stock Option (Right to Buy)
Scott M. Coiante SVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 230,000 230,000 - - Stock Option (Right to Buy)
Ivan H. Cheung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2024 186,685 186,685 - - Stock Option (Right to Buy)
Brian Corrigan SVP, Regulatory & QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 200,000 200,000 - - Stock Option (Right to Buy)
Jeffrey L. Wade President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jul 2024 307,000 307,000 - - Stock Option (Right to Buy)
Michael Exton Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jul 2024 1,675,000 1,675,000 - - Stock Option (Right to Buy)
Raymond Debbane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 44,906 44,906 - - Stock Option (Right to Buy)
Raymond Debbane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 36,810 36,810 - - Restricted Stock Units
Samuel L. Barker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 44,906 44,906 - - Stock Option (Right to Buy)
Samuel L. Barker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 36,810 36,810 - - Restricted Stock Units
Christopher J. Sobecki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 44,906 44,906 - - Stock Option (Right to Buy)
Christopher J. Sobecki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 36,810 36,810 - - Restricted Stock Units
Philippe J. Amouyal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 44,906 44,906 - - Stock Option (Right to Buy)
Philippe J. Amouyal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 36,810 36,810 - - Restricted Stock Units
Judith L. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 44,906 44,906 - - Stock Option (Right to Buy)
Judith L. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 36,810 36,810 - - Restricted Stock Units
Robert J. Lefkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 44,906 44,906 - - Stock Option (Right to Buy)
Robert J. Lefkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 36,810 36,810 - - Restricted Stock Units
Diane E. Sullivan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 36,810 36,810 - - Restricted Stock Units
Diane E. Sullivan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 44,906 44,906 - - Stock Option (Right to Buy)
Raymond Debbane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 1,348,879 (1%) 0% 0 Common Stock
Raymond Debbane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 0 - - Restricted Stock Units
Samuel L. Barker Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 0 - - Restricted Stock Units
Samuel L. Barker Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 87,649 (0%) 0% 0 Common Stock
Christopher J. Sobecki Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 167,055 (0%) 0% 0 Common Stock
Christopher J. Sobecki Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 0 - - Restricted Stock Units
Philippe J. Amouyal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 0 - - Restricted Stock Units
Philippe J. Amouyal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 248,364 (0%) 0% 0 Common Stock
Judith L. Swain Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 48,364 (0%) 0% 0 Common Stock
Judith L. Swain Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 0 - - Restricted Stock Units
Robert J. Lefkowitz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 0 - - Restricted Stock Units
Robert J. Lefkowitz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2024 8,032 48,364 (0%) 0% 0 Common Stock
B. Kassler-Taub Kenneth SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 27,556 154,268 (0%) 0% - Common Stock
Crum T. Brian SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 8,750 0 - - Restricted Stock Units
T. Crum Brian SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 33,457 203,101 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 33,333 0 - - Restricted Stock Units
T. Brian Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 26,096 26,097 - - Restricted Stock Units
B. Kassler-Taub Kenneth SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 7,087 126,712 (0%) 0% - Common Stock
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 37,274 312,792 (0%) 0% - Common Stock
Kassler-Taub Kenneth B. SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 32,757 187,025 (0%) 0% - Common Stock
Crum T. Brian SVP, General Counsel & Secr. Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share. 28 Feb 2024 25,604 177,497 (0%) 0% 2.6 67,082 Common Stock
Alexander L. Kristen VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 15,927 59,593 (0%) 0% - Common Stock
McDermott Wendy E. VP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 18,944 18,943 - - Restricted Stock Units
Craig Granowitz B. SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 27,916 43,101 (0%) 0% - Common Stock
Kassler-Taub Kenneth B. SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 7,087 0 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 32,903 280,132 (0%) 0% - Common Stock
Alexander L. Kristen VP, Finance and Accounting Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share. 28 Feb 2024 11,793 47,800 (0%) 0% 2.6 30,898 Common Stock
McDermott E. Wendy VP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share. 28 Feb 2024 22,425 52,694 (0%) 0% 2.6 58,754 Common Stock
Coats Lonnel Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share. 28 Feb 2024 61,371 1,098,068 (1%) 0% 2.6 160,792 Common Stock
Wade Jeffrey L. President and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share. 28 Feb 2024 37,691 324,214 (0%) 0% 2.6 98,750 Common Stock
Granowitz Craig B. SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 35,790 78,891 (0%) 0% - Common Stock
Jeffrey Wade L. President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 11,177 275,518 (0%) 0% - Common Stock
Kassler-Taub Kenneth B. SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 32,757 65,513 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 10,616 10,617 - - Restricted Stock Units
Coats Lonnel Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 120,383 240,767 - - Restricted Stock Units
Wade Jeffrey L. President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 37,274 37,273 - - Restricted Stock Units
B. Craig Granowitz SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 27,916 27,917 - - Restricted Stock Units
B. Kenneth Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 27,556 27,557 - - Restricted Stock Units
McDermott Wendy E. VP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 27,697 55,393 - - Restricted Stock Units
Coats Lonnel Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 33,333 947,692 (0%) 0% - Common Stock
J. Main Alan EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 25,666 25,667 - - Restricted Stock Units
McDermott Wendy E. VP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 27,697 75,119 (0%) 0% - Common Stock
Crum T. Brian SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 33,457 66,913 - - Restricted Stock Units
Alan Main J. EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 8,977 0 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 32,903 65,807 - - Restricted Stock Units
Crum Brian T. SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 26,096 169,644 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 91,364 91,363 - - Restricted Stock Units
Kristen Alexander L. VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 2,700 0 - - Restricted Stock Units
J. Alan Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 25,666 247,229 (0%) 0% - Common Stock
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 10,616 43,666 (0%) 0% - Common Stock
L. Jeffrey Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 11,177 0 - - Restricted Stock Units
Kristen Alexander L. VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 2,700 33,050 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 91,364 1,039,056 (0%) 0% - Common Stock
Alexander Kristen L. VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 15,927 31,853 - - Restricted Stock Units
Main J. Alan EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 8,977 221,563 (0%) 0% - Common Stock
Jeffrey Wade L. President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 49,113 361,905 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 120,383 1,159,439 (1%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share. 28 Feb 2024 24,408 255,724 (0%) 0% 2.6 63,949 Common Stock
Granowitz B. Craig SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 35,790 71,580 - - Restricted Stock Units
B. Kassler-Taub Kenneth SVP, Regulatory & QA Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share. 28 Feb 2024 24,353 162,672 (0%) 0% 2.6 63,805 Common Stock
McDermott Wendy E. VP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 18,944 47,422 (0%) 0% - Common Stock
Wade Jeffrey L. President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 49,113 98,227 - - Restricted Stock Units
B. Granowitz Craig SVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share. 28 Feb 2024 31,265 47,626 (0%) 0% 2.6 81,914 Common Stock
Crum T. Brian SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 8,750 143,548 (0%) 0% - Common Stock
E. McDermott Wendy VP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 156,950 156,950 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 59,660 59,660 - - Stock Option (Right to Buy)
Granowitz B. Craig SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 222,680 222,680 - - Restricted Stock Units
Lonnel Coats Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 770,420 770,420 - - Restricted Stock Units
B. Kenneth Kassler-Taub SVP, Regulatory & QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 203,810 203,810 - - Stock Option (Right to Buy)
Kenneth B. Kassler-Taub SVP, Regulatory & QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 203,810 203,810 - - Restricted Stock Units
Crum Brian T. SVP, General Counsel & Secr. Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 208,160 208,160 - - Stock Option (Right to Buy)
Lonnel Coats Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 770,420 770,420 - - Stock Option (Right to Buy)
Craig B. Granowitz SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 222,680 222,680 - - Stock Option (Right to Buy)
E. Wendy McDermott VP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 156,950 156,950 - - Stock Option (Right to Buy)
L. Wade Jeffrey President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 314,320 314,320 - - Restricted Stock Units
Wade L. Jeffrey President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 314,320 314,320 - - Stock Option (Right to Buy)
Garner Thomas SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 227,130 227,130 - - Restricted Stock Units
Alexander L. Kristen VP, Finance and Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 59,660 59,660 - - Restricted Stock Units
Main J. Alan EVP, Innov & Chem Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 204,730 204,730 - - Stock Option (Right to Buy)
J. Main Alan EVP, Innov & Chem Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 204,730 204,730 - - Restricted Stock Units
T. Crum Brian SVP, General Counsel & Secr. Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 208,160 208,160 - - Restricted Stock Units
Garner Thomas SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 227,130 227,130 - - Stock Option (Right to Buy)
Wendy E. McDermott VP, Human Resources Purchase of securities on an exchange or from another person at price $ 1.84 per share. 04 Aug 2023 6,000 28,478 (0%) 0% 1.8 11,040 Common Stock
Diane Sullivan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 96,515 96,515 - - Stock Option (Right to Buy)
Lonnel Coats Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.16 per share. 29 Jun 2023 10,000 814,359 (0%) 0% 2.2 21,600 Common Stock
Lonnel Coats Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.50 per share. 23 Jun 2023 10,000 794,359 (0%) 0% 2.5 24,950 Common Stock
Lonnel Coats Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.18 per share. 23 Jun 2023 10,000 804,359 (0%) 0% 2.2 21,792 Common Stock
Wendy E. McDermott VP, Human Resources Purchase of securities on an exchange or from another person at price $ 2.43 per share. 23 Jun 2023 10,000 22,478 (0%) 0% 2.4 24,300 Common Stock
Lonnel Coats Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.31 per share. 22 Jun 2023 40,000 784,359 (0%) 0% 2.3 92,400 Common Stock
Jeffrey L. Wade President and CFO Purchase of securities on an exchange or from another person at price $ 2.32 per share. 20 Jun 2023 2,000 254,341 (0%) 0% 2.3 4,650 Common Stock
Jeffrey L. Wade President and CFO Purchase of securities on an exchange or from another person at price $ 2.34 per share. 20 Jun 2023 10,000 252,341 (0%) 0% 2.3 23,350 Common Stock
Frank P. Palantoni Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 40,332 (0%) 0% 0 Common Stock
Frank P. Palantoni Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 0 - - Restricted Stock Units
Raymond Debbane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 0 - - Restricted Stock Units
Raymond Debbane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 340,847 (0%) 0% 0 Common Stock
Samuel L. Barker Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 79,617 (0%) 0% 0 Common Stock
Samuel L. Barker Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 0 - - Restricted Stock Units
Alan S. Nies Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 41,046 (0%) 0% 0 Common Stock
Alan S. Nies Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 0 - - Restricted Stock Units
Christopher J. Sobecki Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 159,023 (0%) 0% 0 Common Stock
Christopher J. Sobecki Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 0 - - Restricted Stock Units
Philippe J. Amouyal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 0 - - Restricted Stock Units
Philippe J. Amouyal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 40,332 (0%) 0% 0 Common Stock
Judith L. Swain Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 0 - - Restricted Stock Units
Judith L. Swain Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 40,332 (0%) 0% 0 Common Stock
Robert J. Lefkowitz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 0 - - Restricted Stock Units
Robert J. Lefkowitz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2023 9,302 40,332 (0%) 0% 0 Common Stock
Frank P. Palantoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 12,658 12,658 - - Stock Option (Right to Buy)
Frank P. Palantoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 8,032 8,032 - - Restricted Stock Units
Alan S. Nies Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 8,032 8,032 - - Restricted Stock Units
Alan S. Nies Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 12,658 12,658 - - Stock Option (Right to Buy)
Christopher J. Sobecki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 8,032 8,032 - - Restricted Stock Units
Christopher J. Sobecki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 12,658 12,658 - - Stock Option (Right to Buy)
Philippe J. Amouyal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 12,658 12,658 - - Stock Option (Right to Buy)
Philippe J. Amouyal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 8,032 8,032 - - Restricted Stock Units
Judith L. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 8,032 8,032 - - Restricted Stock Units
Judith L. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 12,658 12,658 - - Stock Option (Right to Buy)
Robert J. Lefkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 8,032 8,032 - - Restricted Stock Units
Robert J. Lefkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 12,658 12,658 - - Stock Option (Right to Buy)
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 23,300 0 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. 28 Feb 2023 20,946 212,586 (0%) 0% 2.2 45,453 Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 8,976 8,977 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 25,667 233,532 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 8,976 207,865 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 25,667 51,333 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 23,300 198,889 (0%) 0% - Common Stock
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 37,273 74,547 - - Restricted Stock Units
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 11,176 11,177 - - Restricted Stock Units
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 30,467 0 - - Restricted Stock Units
Jeffrey L. Wade President and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. 28 Feb 2023 30,255 242,341 (0%) 0% 2.2 65,653 Common Stock
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 37,273 272,596 (0%) 0% - Common Stock
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 11,176 235,323 (0%) 0% - Common Stock
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 30,467 224,147 (0%) 0% - Common Stock
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 26,097 52,193 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 8,750 8,750 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 21,030 0 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. 28 Feb 2023 20,537 134,798 (0%) 0% 2.2 44,565 Common Stock
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 26,097 155,335 (0%) 0% - Common Stock
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 8,750 129,238 (0%) 0% - Common Stock
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 21,030 120,488 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 84,630 0 - - Restricted Stock Units
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 84,630 670,633 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 33,334 703,967 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 91,363 795,330 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. 28 Feb 2023 50,971 744,359 (0%) 0% 2.2 110,607 Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 33,334 33,333 - - Restricted Stock Units
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 91,363 182,727 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 10,617 21,233 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 2,700 2,700 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 5,400 0 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. 28 Feb 2023 5,330 30,350 (0%) 0% 2.2 11,566 Common Stock
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 10,617 35,680 (0%) 0% - Common Stock
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 2,700 25,063 (0%) 0% - Common Stock
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 5,400 22,363 (0%) 0% - Common Stock
Craig B. Granowitz SVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. 28 Feb 2023 12,732 15,185 (0%) 0% 2.2 27,628 Common Stock
Craig B. Granowitz SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 27,917 27,917 (0%) 0% - Common Stock
Craig B. Granowitz SVP, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 27,917 55,833 - - Restricted Stock Units
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 18,243 104,100 (0%) 0% - Common Stock
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 27,557 55,113 - - Restricted Stock Units
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 7,086 7,087 - - Restricted Stock Units
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 18,243 0 - - Restricted Stock Units
Kenneth B. Kassler-Taub SVP, Regulatory & QA Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. 28 Feb 2023 19,118 119,625 (0%) 0% 2.2 41,486 Common Stock
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 27,557 138,743 (0%) 0% - Common Stock
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 7,086 111,186 (0%) 0% - Common Stock
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 22,963 45,927 - - Restricted Stock Units
Kiernan A. Seth VP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. 28 Feb 2023 11,813 53,136 (0%) 0% 2.2 25,634 Common Stock
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 14,833 0 - - Restricted Stock Units
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 5,286 5,287 - - Restricted Stock Units
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 14,833 36,700 (0%) 0% - Common Stock
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 5,286 41,986 (0%) 0% - Common Stock
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 22,963 64,949 (0%) 0% - Common Stock
Wendy E. McDermott VP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 18,943 18,943 (0%) 0% - Common Stock
Wendy E. McDermott VP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2023 18,943 37,887 - - Restricted Stock Units
Wendy E. McDermott VP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. 28 Feb 2023 6,465 12,478 (0%) 0% 2.2 14,029 Common Stock
Alan J. Main EVP, Innov & Chem Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 296,130 296,130 - - Stock Option (Right to Buy)
Alan J. Main EVP, Innov & Chem Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 98,710 98,710 - - Restricted Stock Units
Jeffrey L. Wade President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 147,340 147,340 - - Restricted Stock Units
Jeffrey L. Wade President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 442,030 442,030 - - Stock Option (Right to Buy)
Brian T. Crum SVP, General Counsel & Secr. Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 100,370 100,370 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 301,100 301,100 - - Stock Option (Right to Buy)
Lonnel Coats Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 1,083,440 1,083,440 - - Stock Option (Right to Buy)
Lonnel Coats Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 361,150 361,150 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 71,670 71,670 - - Stock Option (Right to Buy)
Kristen L. Alexander VP, Finance and Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 47,780 47,780 - - Restricted Stock Units
Craig B. Granowitz SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 322,110 322,110 - - Stock Option (Right to Buy)
Craig B. Granowitz SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 107,370 107,370 - - Restricted Stock Units
Kenneth B. Kassler-Taub SVP, Regulatory & QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 98,270 98,270 - - Restricted Stock Units
Kenneth B. Kassler-Taub SVP, Regulatory & QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 294,810 294,810 - - Stock Option (Right to Buy)
Kiernan A. Seth VP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 280,100 280,100 - - Stock Option (Right to Buy)
Kiernan A. Seth VP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 93,370 93,370 - - Restricted Stock Units
Wendy E. McDermott VP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 83,090 83,090 - - Restricted Stock Units
Wendy E. McDermott VP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 249,280 249,280 - - Stock Option (Right to Buy)
Raymond Debbane Director Purchase of securities on an exchange or from another person at price $ 2.50 per share. 01 Aug 2022 982,600 5,303,814 (4%) 0% 2.5 2,456,500 Common Stock
Frank P. Palantoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 14,402 14,402 - - Stock Option (Right to Buy)
Frank P. Palantoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 9,302 9,302 - - Restricted Stock Units
Raymond Debbane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 9,302 9,302 - - Restricted Stock Units
Raymond Debbane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 14,402 14,402 - - Stock Option (Right to Buy)
Samuel L. Barker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 14,402 14,402 - - Stock Option (Right to Buy)
Samuel L. Barker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 9,302 9,302 - - Restricted Stock Units
Alan S. Nies Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 9,302 9,302 - - Restricted Stock Units
Alan S. Nies Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 14,402 14,402 - - Stock Option (Right to Buy)
Christopher J. Sobecki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 14,402 14,402 - - Stock Option (Right to Buy)
Christopher J. Sobecki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 9,302 9,302 - - Restricted Stock Units
Philippe J. Amouyal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 9,302 9,302 - - Restricted Stock Units
Philippe J. Amouyal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 14,402 14,402 - - Stock Option (Right to Buy)
Judith L. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 14,402 14,402 - - Stock Option (Right to Buy)
Judith L. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 9,302 9,302 - - Restricted Stock Units
Robert J. Lefkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 9,302 9,302 - - Restricted Stock Units
Robert J. Lefkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2022 14,402 14,402 - - Stock Option (Right to Buy)
Frank P. Palantoni Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 0 - - Restricted Stock Units
Frank P. Palantoni Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 31,030 (0%) 0% 0 Common Stock
Raymond Debbane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 331,545 (0%) 0% 0 Common Stock
Raymond Debbane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 0 - - Restricted Stock Units
Samuel L. Barker Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 70,315 (0%) 0% 0 Common Stock
Samuel L. Barker Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 0 - - Restricted Stock Units
Alan S. Nies Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 31,744 (0%) 0% 0 Common Stock
Alan S. Nies Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 0 - - Restricted Stock Units
Christopher J. Sobecki Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 149,721 (0%) 0% 0 Common Stock
Christopher J. Sobecki Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 0 - - Restricted Stock Units
Philippe J. Amouyal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 0 - - Restricted Stock Units
Philippe J. Amouyal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 31,030 (0%) 0% 0 Common Stock
Judith L. Swain Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 31,030 (0%) 0% 0 Common Stock
Judith L. Swain Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 0 - - Restricted Stock Units
Robert J. Lefkowitz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 31,030 (0%) 0% 0 Common Stock
Robert J. Lefkowitz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 4,024 0 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 22,373 163,068 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 8,977 17,953 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 22,373 0 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 23,300 23,300 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. 28 Feb 2022 19,756 175,589 (0%) 0% 2.9 56,305 Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 8,977 195,345 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 23,300 186,368 (0%) 0% - Common Stock
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 30,466 30,467 - - Restricted Stock Units
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 11,177 22,353 - - Restricted Stock Units
Jeffrey L. Wade President and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. 28 Feb 2022 25,773 193,680 (0%) 0% 2.8 73,453 Common Stock
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 11,177 219,453 (0%) 0% - Common Stock
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 30,466 208,276 (0%) 0% - Common Stock
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 25,290 177,810 (0%) 0% - Common Stock
Jeffrey L. Wade President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 25,290 0 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. 28 Feb 2022 15,059 99,458 (0%) 0% 2.8 42,918 Common Stock
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 8,750 114,517 (0%) 0% - Common Stock
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 21,030 105,767 (0%) 0% - Common Stock
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 11,100 84,737 (0%) 0% - Common Stock
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 21,030 21,030 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 8,750 17,500 - - Restricted Stock Units
Brian T. Crum SVP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 11,100 0 - - Restricted Stock Units
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 79,380 0 - - Restricted Stock Units
Lonnel Coats Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. 28 Feb 2022 48,053 586,003 (0%) 0% 2.8 136,951 Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 33,333 634,056 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 84,630 600,723 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 79,380 516,093 (0%) 0% - Common Stock
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 33,333 66,667 - - Restricted Stock Units
Lonnel Coats Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 84,630 84,630 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 2,700 20,300 (0%) 0% - Common Stock
Kristen L. Alexander VP, Finance and Accounting Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. 28 Feb 2022 3,337 16,963 (0%) 0% 2.8 9,510 Common Stock
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 3,200 0 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 5,400 5,400 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 2,700 5,400 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 3,200 12,200 (0%) 0% - Common Stock
Kristen L. Alexander VP, Finance and Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 5,400 17,600 (0%) 0% - Common Stock
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 11,297 0 - - Restricted Stock Units
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 11,297 73,767 (0%) 0% - Common Stock
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 18,244 92,011 (0%) 0% - Common Stock
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 7,087 99,098 (0%) 0% - Common Stock
Kenneth B. Kassler-Taub SVP, Regulatory & QA Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. 28 Feb 2022 13,241 85,857 (0%) 0% 2.9 37,737 Common Stock
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 18,244 18,243 - - Restricted Stock Units
Kenneth B. Kassler-Taub SVP, Regulatory & QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 7,087 14,173 - - Restricted Stock Units
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 5,287 10,573 - - Restricted Stock Units
Kiernan A. Seth VP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. 28 Feb 2022 8,261 21,867 (0%) 0% 2.9 23,544 Common Stock
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 5,287 30,128 (0%) 0% - Common Stock
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 14,834 24,841 (0%) 0% - Common Stock
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 10,007 10,007 (0%) 0% - Common Stock
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 14,834 14,833 - - Restricted Stock Units
Kiernan A. Seth VP, Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 10,007 0 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 230,990 230,990 - - Stock Option (Right to Buy)
Alan J. Main EVP, Innov & Chem Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 77,000 77,000 - - Restricted Stock Units
Jeffrey L. Wade President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 111,820 111,820 - - Restricted Stock Units
Jeffrey L. Wade President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 335,470 335,470 - - Stock Option (Right to Buy)
Brian T. Crum SVP, General Counsel & Secr. Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 234,870 234,870 - - Stock Option (Right to Buy)
Brian T. Crum SVP, General Counsel & Secr. Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 78,290 78,290 - - Restricted Stock Units
Lonnel Coats Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 822,280 822,280 - - Stock Option (Right to Buy)
Lonnel Coats Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 274,090 274,090 - - Restricted Stock Units
Kristen L. Alexander VP, Finance and Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 47,780 47,780 - - Stock Option (Right to Buy)
Kristen L. Alexander VP, Finance and Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 31,850 31,850 - - Restricted Stock Units
Craig B. Granowitz SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 83,750 83,750 - - Restricted Stock Units
Craig B. Granowitz SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 251,250 251,250 - - Stock Option (Right to Buy)
Kenneth B. Kassler-Taub SVP, Regulatory & QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 82,670 82,670 - - Restricted Stock Units
Kenneth B. Kassler-Taub SVP, Regulatory & QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 248,010 248,010 - - Stock Option (Right to Buy)
Kiernan A. Seth VP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 206,670 206,670 - - Stock Option (Right to Buy)
Kiernan A. Seth VP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 68,890 68,890 - - Restricted Stock Units
Wendy E. McDermott VP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 170,500 170,500 - - Stock Option (Right to Buy)
Wendy E. McDermott VP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 56,830 56,830 - - Restricted Stock Units
Wendy E. McDermott VP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 85,185 85,185 - - Stock Option (Right to Buy)
Craig B. Granowitz SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 250,000 250,000 - - Stock Option (Right to Buy)
Frank P. Palantoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 4,024 4,024 - - Restricted Stock Units
Frank P. Palantoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 6,475 6,475 - - Stock Option (Right to Buy)
Raymond Debbane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 6,475 6,475 - - Stock Option (Right to Buy)
Raymond Debbane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 4,024 4,024 - - Restricted Stock Units
Samuel L. Barker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 4,024 4,024 - - Restricted Stock Units
Samuel L. Barker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 6,475 6,475 - - Stock Option (Right to Buy)
Alan S. Nies Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 4,024 4,024 - - Restricted Stock Units
Alan S. Nies Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 6,475 6,475 - - Stock Option (Right to Buy)
Christopher J. Sobecki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 4,024 4,024 - - Restricted Stock Units
Christopher J. Sobecki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 6,475 6,475 - - Stock Option (Right to Buy)
Philippe J. Amouyal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 6,475 6,475 - - Stock Option (Right to Buy)
Philippe J. Amouyal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 4,024 4,024 - - Restricted Stock Units
Judith L. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 4,024 4,024 - - Restricted Stock Units
Judith L. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 6,475 6,475 - - Stock Option (Right to Buy)
Robert J. Lefkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 4,024 4,024 - - Restricted Stock Units
Robert J. Lefkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 6,475 6,475 - - Stock Option (Right to Buy)
Frank P. Palantoni Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 0 - - Restricted Stock Units
Frank P. Palantoni Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 27,006 (0%) 0% 0 Common Stock
Raymond Debbane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 0 - - Restricted Stock Units
Raymond Debbane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 327,521 (0%) 0% 0 Common Stock
Samuel L. Barker Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 0 - - Restricted Stock Units
Samuel L. Barker Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 66,291 (0%) 0% 0 Common Stock
Alan S. Nies Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 27,720 (0%) 0% 0 Common Stock
Alan S. Nies Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 0 - - Restricted Stock Units
Christopher J. Sobecki Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 0 - - Restricted Stock Units
Christopher J. Sobecki Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 151,397 (0%) 0% 0 Common Stock
Philippe J. Amouyal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 0 - - Restricted Stock Units
Philippe J. Amouyal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 27,006 (0%) 0% 0 Common Stock
Judith L. Swain Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 27,006 (0%) 0% 0 Common Stock
Judith L. Swain Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 0 - - Restricted Stock Units
Robert J. Lefkowitz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 0 - - Restricted Stock Units
Robert J. Lefkowitz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2021 10,638 27,006 (0%) 0% 0 Common Stock
James F. Tessmer VP, Finance & Accounting Sale of securities on an exchange or to another person at price $ 6.92 per share. 15 Mar 2021 12,000 71,766 (0%) 0% 6.9 83,100 Common Stock
James F. Tessmer VP, Finance & Accounting Sale of securities on an exchange or to another person at price $ 6.90 per share. 15 Mar 2021 10,912 71,766 (0%) 0% 6.9 75,340 Common Stock
James F. Tessmer VP, Finance & Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.31 per share. 15 Mar 2021 12,000 83,766 (0%) 0% 3.3 39,720 Common Stock
James F. Tessmer VP, Finance & Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2021 12,000 50,980 - - Stock Option (Right to Buy)
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 23,300 46,600 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 2,497 107,137 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 8,297 115,434 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 22,374 137,808 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 23,300 161,108 (0%) 0% - Common Stock
Alan J. Main EVP, Innov & Chem Sciences Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. 28 Feb 2021 20,413 140,695 (0%) 0% 7.2 146,769 Common Stock
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 2,497 0 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 8,297 0 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 22,374 22,373 - - Restricted Stock Units
James F. Tessmer VP, Finance & Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 1,270 66,397 (0%) 0% - Common Stock
James F. Tessmer VP, Finance & Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 13,997 27,993 - - Restricted Stock Units
James F. Tessmer VP, Finance & Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 8,836 8,837 - - Restricted Stock Units
James F. Tessmer VP, Finance & Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 4,213 0 - - Restricted Stock Units
James F. Tessmer VP, Finance & Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 1,270 0 - - Restricted Stock Units
James F. Tessmer VP, Finance & Accounting Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. 28 Feb 2021 10,765 82,678 (0%) 0% 7.2 77,400 Common Stock
James F. Tessmer VP, Finance & Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 13,997 93,443 (0%) 0% - Common Stock
James F. Tessmer VP, Finance & Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 8,836 79,446 (0%) 0% - Common Stock
James F. Tessmer VP, Finance & Accounting Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 4,213 70,610 (0%) 0% - Common Stock
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 2,797 118,292 (0%) 0% - Common Stock
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 30,467 60,933 - - Restricted Stock Units
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 25,290 25,290 - - Restricted Stock Units
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 9,555 0 - - Restricted Stock Units
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 2,797 0 - - Restricted Stock Units
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. 28 Feb 2021 26,584 157,020 (0%) 0% 7.2 191,139 Common Stock
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 30,467 183,604 (0%) 0% - Common Stock
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 25,290 153,137 (0%) 0% - Common Stock
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 9,555 127,847 (0%) 0% - Common Stock
Praveen Tyle EVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 9,727 82,061 (0%) 0% - Common Stock
Praveen Tyle EVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 28,690 57,380 - - Restricted Stock Units
Praveen Tyle EVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 26,600 26,600 - - Restricted Stock Units
Praveen Tyle EVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 9,727 0 - - Restricted Stock Units
Praveen Tyle EVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 2,990 0 - - Restricted Stock Units
Praveen Tyle EVP, R&D Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. 28 Feb 2021 16,560 120,791 (0%) 0% 7.2 119,066 Common Stock
Praveen Tyle EVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 28,690 137,351 (0%) 0% - Common Stock
Praveen Tyle EVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 26,600 108,661 (0%) 0% - Common Stock
Praveen Tyle EVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 2,990 72,334 (0%) 0% - Common Stock
Brian T. Crum VP, General Counsel & Secr. Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. 28 Feb 2021 14,860 73,637 (0%) 0% 7.2 106,843 Common Stock
Brian T. Crum VP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 21,030 42,060 - - Restricted Stock Units
Brian T. Crum VP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 11,100 11,100 - - Restricted Stock Units
Brian T. Crum VP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 5,118 0 - - Restricted Stock Units
Brian T. Crum VP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 1,517 0 - - Restricted Stock Units
Brian T. Crum VP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 21,030 88,497 (0%) 0% - Common Stock
Brian T. Crum VP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 11,100 67,467 (0%) 0% - Common Stock
Brian T. Crum VP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 5,118 56,367 (0%) 0% - Common Stock
Brian T. Crum VP, General Counsel & Secr. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 1,517 51,249 (0%) 0% - Common Stock
Lonnel Coats Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 5,362 304,228 (0%) 0% - Common Stock
Lonnel Coats Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 23,513 327,741 (0%) 0% - Common Stock
Lonnel Coats Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 79,380 407,121 (0%) 0% - Common Stock
Lonnel Coats Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 84,630 491,751 (0%) 0% - Common Stock
Lonnel Coats Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. 28 Feb 2021 55,038 436,713 (0%) 0% 7.2 395,723 Common Stock
Lonnel Coats Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 5,362 0 - - Restricted Stock Units
Lonnel Coats Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 23,513 0 - - Restricted Stock Units
Lonnel Coats Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 79,380 79,380 - - Restricted Stock Units
Lonnel Coats Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2021 84,630 169,260 - - Restricted Stock Units
Alan J. Main EVP, Innov & Chem Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 80,780 80,780 - - Stock Option (Right to Buy)
Alan J. Main EVP, Innov & Chem Sciences Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 26,930 26,930 - - Restricted Stock Units
James F. Tessmer VP, Finance & Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 24,340 24,340 - - Stock Option (Right to Buy)
James F. Tessmer VP, Finance & Accounting Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 16,230 16,230 - - Restricted Stock Units
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 33,530 33,530 - - Restricted Stock Units
Jeffrey L. Wade EVP, Corp Adm Affairs and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 100,600 100,600 - - Stock Option (Right to Buy)
Praveen Tyle EVP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 32,100 32,100 - - Restricted Stock Units
Praveen Tyle EVP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 96,310 96,310 - - Stock Option (Right to Buy)
Brian T. Crum VP, General Counsel & Secr. Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 78,760 78,760 - - Stock Option (Right to Buy)
Brian T. Crum VP, General Counsel & Secr. Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 26,250 26,250 - - Restricted Stock Units
Lonnel Coats Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 300,000 300,000 - - Stock Option (Right to Buy)
Lonnel Coats Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 100,000 100,000 - - Restricted Stock Units
Frank P. Palantoni Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 16,368 (0%) 0% 0 Common Stock
Frank P. Palantoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 18,115 18,115 - - Stock Option (Right to Buy)
Frank P. Palantoni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 10,638 10,638 - - Restricted Stock Units
Frank P. Palantoni Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 0 - - Restricted Stock Units
Raymond Debbane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 0 - - Restricted Stock Units
Raymond Debbane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 316,883 (0%) 0% 0 Common Stock
Raymond Debbane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 18,115 18,115 - - Stock Option (Right to Buy)
Raymond Debbane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 10,638 10,638 - - Restricted Stock Units
Samuel L. Barker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 18,115 18,115 - - Stock Option (Right to Buy)
Samuel L. Barker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 10,638 10,638 - - Restricted Stock Units
Samuel L. Barker Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 0 - - Restricted Stock Units
Samuel L. Barker Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 55,653 (0%) 0% 0 Common Stock
Alan S. Nies Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 10,638 10,638 - - Restricted Stock Units
Alan S. Nies Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 0 - - Restricted Stock Units
Alan S. Nies Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 18,115 18,115 - - Stock Option (Right to Buy)
Alan S. Nies Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 17,082 (0%) 0% 0 Common Stock
Christopher J. Sobecki Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 140,759 (0%) 0% 0 Common Stock
Christopher J. Sobecki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 18,115 18,115 - - Stock Option (Right to Buy)
Christopher J. Sobecki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 10,638 10,638 - - Restricted Stock Units
Christopher J. Sobecki Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 0 - - Restricted Stock Units
Philippe J. Amouyal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 18,115 18,115 - - Stock Option (Right to Buy)
Philippe J. Amouyal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 0 - - Restricted Stock Units
Philippe J. Amouyal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 10,638 10,638 - - Restricted Stock Units
Philippe J. Amouyal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 16,368 (0%) 0% 0 Common Stock
Judith L. Swain Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 16,368 (0%) 0% 0 Common Stock
Judith L. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 18,115 18,115 - - Stock Option (Right to Buy)
Judith L. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 10,638 10,638 - - Restricted Stock Units
Judith L. Swain Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 0 - - Restricted Stock Units
Robert J. Lefkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 10,638 10,638 - - Restricted Stock Units
Robert J. Lefkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2020 18,115 18,115 - - Stock Option (Right to Buy)
Robert J. Lefkowitz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 16,368 (0%) 0% 0 Common Stock
Robert J. Lefkowitz Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2020 3,466 0 - - Restricted Stock Units
Alan J. Main EVP, Commercial Supply Ops Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.96 per share. 22 Apr 2020 6,813 104,640 (0%) 0% 2.0 13,353 Common Stock
Alan J. Main EVP, Commercial Supply Ops Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2020 19,893 111,453 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures